On the menu for this week’s potpourri–savings from wellness efforts for a large employer; drug reimbursement for Medicaid programs; using remote monitoring in a health plan context; the FDA’s regulatory approach to mobile health uses; the effect of tort reform on imaging rates and hepatitis C pay-for-performance measures.
The meaningful use provisions of the stimulus bill provide incentive payments to providers who implement EMRs, and ultimately penalties for those who don’t or who don’t use those systems in certain ways. A pair of new briefs outline challenges for providers to meet the meaningful use requirements.
The Office of Actuary publishes its current estimate of national health spending in the wake of health reform. It finds that the law will slightly increase spending, but there is a big caveat because the projections assume Medicare payment cuts will stay in place.
Fall is a lovely time of year and what could be better than relaxing with a Potpourri, featuring health insurance increases, the true costs of EHRs, hospital pay-for-performance programs and quality, the impact of social networks on health behavior, and unenrolled Medicaid-eligible children.
We have certainly labored over the Labor Day weekend version of the Potpourri, featuring relative performance of US and foreign medical school graduates, California health insurance hikes, non-for-profit hospital CEO pay, performance measures and outcome variation at hospitals related to cost, new reimbursement methods and physician cost profiling.